GUFICBIO.BOGUFICBIO.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.98% | +1.61% | +10.31% | +16.10% | +11.37% |
| Gross Profit Growth | +58.48% | +0.33% | +64.55% | +22.73% | -27.30% |
| EBITDA Growth | -2.96% | -27.42% | -7.58% | +3.18% | -7.85% |
| Operating Income Growth | -9.31% | -42.65% | -18.72% | -12.37% | -13.72% |
| Net Income Growth | -13.26% | -61.49% | -37.33% | -22.71% | -35.65% |
| EPS Growth | -13.45% | -61.50% | -37.50% | -22.58% | -35.75% |
| EPS Diluted Growth | -13.45% | -61.50% | -37.50% | -22.58% | -35.75% |
| Weighted Average Shares Growth | +0.22% | -0.35% | +0.27% | -0.17% | +0.26% |
| Weighted Average Shares Diluted Growth | +0.22% | -0.25% | +0.27% | -0.17% | +0.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -4.66% | +0.00% | +92223.00% | +0.00% |
| Inventory Growth | +0.00% | +8.17% | +0.00% | +22.92% | +0.00% |
| Asset Growth | +0.00% | +7.03% | +0.00% | +15.07% | +0.00% |
| Book Value per Share Growth | +46.65% | +13.26% | +12.56% | +10.11% | +0.00% |
| Debt Growth | +0.00% | +0.98% | +0.00% | +24.76% | +0.00% |
| R&D Expense Growth | +0.00% | +3.63% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | +60.88% | -100.00% | +0.00% | +0.00% |